 | • レポートコード：B-GIR08C0045 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、日光角化症の薬の世界市場について調べ、まとめました。種類別セグメントは、ヌクレオシド代謝阻害剤、免疫調節剤、光増感剤、NSAID等、用途別セグメントは、病院、薬局、診断センター、その他等に区分しました。日光角化症の薬の世界市場概観、企業動向、企業別日光角化症の薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・日光角化症の薬の市場概観 ・日光角化症の薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・日光角化症の薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・日光角化症の薬の世界市場規模 ・日光角化症の薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・日光角化症の薬のアメリカ市場規模推移 ・日光角化症の薬のカナダ市場規模推移 ・日光角化症の薬のメキシコ市場規模推移 ・日光角化症の薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・日光角化症の薬のドイツ市場規模推移 ・日光角化症の薬のイギリス市場規模推移 ・日光角化症の薬のロシア市場規模推移 ・日光角化症の薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・日光角化症の薬の日本市場規模推移 ・日光角化症の薬の中国市場規模推移 ・日光角化症の薬の韓国市場規模推移 ・日光角化症の薬のインド市場規模推移 ・日光角化症の薬の東南アジア市場規模推移 ・日光角化症の薬の南米市場分析（ブラジル、アルゼンチン等） ・日光角化症の薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・日光角化症の薬の種類別分析/販売量、売上、市場シェア（ヌクレオシド代謝阻害剤、免疫調節剤、光増感剤、NSAID） ・日光角化症の薬の用途別分析/市場規模（病院、薬局、診断センター、その他） ・日光角化症の薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・日光角化症の薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Actinic Keratosis Drugs is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Actinic Keratosis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
GALDERMA
Almirall
Valeant
Biofrontera
Novartis
Perrigo
LEO Pharma
Vidac Pharma
TOLMAR Pharmaceuticals
Promius Pharma
Taro Pharmaceutical Industries
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Nucleoside Metabolic Inhibitors
Immunomodulators
Photosensitizing Agents
NSAIDs
Market Segment by Applications, can be divided into
Hospitals
Pharmacies
Diagnostic Centers
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Actinic Keratosis Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Actinic Keratosis Drugs, with price, sales, revenue and global market share of Actinic Keratosis Drugs in 2017 and 2018.
Chapter 3, the Actinic Keratosis Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Actinic Keratosis Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Actinic Keratosis Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Actinic Keratosis Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Actinic Keratosis Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Nucleoside Metabolic Inhibitors
1.2.2 Immunomodulators
1.2.3 Photosensitizing Agents
1.2.4 NSAIDs
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Pharmacies
1.3.3 Diagnostic Centers
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GALDERMA
2.1.1 Business Overview
2.1.2 Actinic Keratosis Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GALDERMA Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Almirall
2.2.1 Business Overview
2.2.2 Actinic Keratosis Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Almirall Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Valeant
2.3.1 Business Overview
2.3.2 Actinic Keratosis Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Valeant Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Biofrontera
2.4.1 Business Overview
2.4.2 Actinic Keratosis Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biofrontera Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Actinic Keratosis Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Perrigo
2.6.1 Business Overview
2.6.2 Actinic Keratosis Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Perrigo Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 LEO Pharma
2.7.1 Business Overview
2.7.2 Actinic Keratosis Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 LEO Pharma Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Vidac Pharma
2.8.1 Business Overview
2.8.2 Actinic Keratosis Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Vidac Pharma Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 TOLMAR Pharmaceuticals
2.9.1 Business Overview
2.9.2 Actinic Keratosis Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 TOLMAR Pharmaceuticals Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Promius Pharma
2.10.1 Business Overview
2.10.2 Actinic Keratosis Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Promius Pharma Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Taro Pharmaceutical Industries
2.11.1 Business Overview
2.11.2 Actinic Keratosis Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Taro Pharmaceutical Industries Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Actinic Keratosis Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Actinic Keratosis Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Actinic Keratosis Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Actinic Keratosis Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Actinic Keratosis Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Actinic Keratosis Drugs Market Analysis by Regions
4.1 Global Actinic Keratosis Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Actinic Keratosis Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Actinic Keratosis Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
4.5 South America Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
5 North America Actinic Keratosis Drugs by Country
5.1 North America Actinic Keratosis Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Actinic Keratosis Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Actinic Keratosis Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
6 Europe Actinic Keratosis Drugs by Country
6.1 Europe Actinic Keratosis Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Actinic Keratosis Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Actinic Keratosis Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
6.3 UK Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
6.4 France Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Actinic Keratosis Drugs by Country
7.1 Asia-Pacific Actinic Keratosis Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Actinic Keratosis Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Actinic Keratosis Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
7.5 India Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
8 South America Actinic Keratosis Drugs by Country
8.1 South America Actinic Keratosis Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Actinic Keratosis Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Actinic Keratosis Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Actinic Keratosis Drugs by Countries
9.1 Middle East and Africa Actinic Keratosis Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Actinic Keratosis Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Actinic Keratosis Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
10 Global Actinic Keratosis Drugs Market Segment by Type
10.1 Global Actinic Keratosis Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Actinic Keratosis Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Actinic Keratosis Drugs Revenue and Market Share by Type (2014-2019)
10.2 Nucleoside Metabolic Inhibitors Sales Growth and Price
10.2.1 Global Nucleoside Metabolic Inhibitors Sales Growth (2014-2019)
10.2.2 Global Nucleoside Metabolic Inhibitors Price (2014-2019)
10.3 Immunomodulators Sales Growth and Price
10.3.1 Global Immunomodulators Sales Growth (2014-2019)
10.3.2 Global Immunomodulators Price (2014-2019)
10.4 Photosensitizing Agents Sales Growth and Price
10.4.1 Global Photosensitizing Agents Sales Growth (2014-2019)
10.4.2 Global Photosensitizing Agents Price (2014-2019)
10.5 NSAIDs Sales Growth and Price
10.5.1 Global NSAIDs Sales Growth (2014-2019)
10.5.2 Global NSAIDs Price (2014-2019)
11 Global Actinic Keratosis Drugs Market Segment by Application
11.1 Global Actinic Keratosis Drugs Sales Market Share by Application (2014-2019)
11.2 Hospitals Sales Growth (2014-2019)
11.3 Pharmacies Sales Growth (2014-2019)
11.4 Diagnostic Centers Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Actinic Keratosis Drugs Market Forecast (2019-2024)
12.1 Global Actinic Keratosis Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Actinic Keratosis Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Actinic Keratosis Drugs Market Forecast (2019-2024)
12.2.2 Europe Actinic Keratosis Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Actinic Keratosis Drugs Market Forecast (2019-2024)
12.2.4 South America Actinic Keratosis Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Actinic Keratosis Drugs Market Forecast (2019-2024)
12.3 Actinic Keratosis Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Actinic Keratosis Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Actinic Keratosis Drugs Market Share Forecast by Type (2019-2024)
12.4 Actinic Keratosis Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Actinic Keratosis Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Actinic Keratosis Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Actinic Keratosis Drugs Picture
Table Product Specifications of Actinic Keratosis Drugs
Figure Global Sales Market Share of Actinic Keratosis Drugs by Types in 2018
Table Actinic Keratosis Drugs Types for Major Manufacturers
Figure Nucleoside Metabolic Inhibitors Picture
Figure Immunomodulators Picture
Figure Photosensitizing Agents Picture
Figure NSAIDs Picture
Figure Actinic Keratosis Drugs Sales Market Share by Applications in 2018
Figure Hospitals Picture
Figure Pharmacies Picture
Figure Diagnostic Centers Picture
Figure Other Picture
Figure United States Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Actinic Keratosis Drugs Revenue (Value) and Growth Rate (2014-2024)
Table GALDERMA Basic Information, Manufacturing Base and Competitors
Table GALDERMA Actinic Keratosis Drugs Type and Applications
Table GALDERMA Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Almirall Basic Information, Manufacturing Base and Competitors
Table Almirall Actinic Keratosis Drugs Type and Applications
Table Almirall Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Valeant Basic Information, Manufacturing Base and Competitors
Table Valeant Actinic Keratosis Drugs Type and Applications
Table Valeant Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biofrontera Basic Information, Manufacturing Base and Competitors
Table Biofrontera Actinic Keratosis Drugs Type and Applications
Table Biofrontera Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Actinic Keratosis Drugs Type and Applications
Table Novartis Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Perrigo Basic Information, Manufacturing Base and Competitors
Table Perrigo Actinic Keratosis Drugs Type and Applications
Table Perrigo Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table LEO Pharma Basic Information, Manufacturing Base and Competitors
Table LEO Pharma Actinic Keratosis Drugs Type and Applications
Table LEO Pharma Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Vidac Pharma Basic Information, Manufacturing Base and Competitors
Table Vidac Pharma Actinic Keratosis Drugs Type and Applications
Table Vidac Pharma Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table TOLMAR Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table TOLMAR Pharmaceuticals Actinic Keratosis Drugs Type and Applications
Table TOLMAR Pharmaceuticals Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Promius Pharma Basic Information, Manufacturing Base and Competitors
Table Promius Pharma Actinic Keratosis Drugs Type and Applications
Table Promius Pharma Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Taro Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Taro Pharmaceutical Industries Actinic Keratosis Drugs Type and Applications
Table Taro Pharmaceutical Industries Actinic Keratosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Actinic Keratosis Drugs Sales by Manufacturer (2017-2018)
Figure Global Actinic Keratosis Drugs Sales Market Share by Manufacturer in 2017
Figure Global Actinic Keratosis Drugs Sales Market Share by Manufacturer in 2018
Table Global Actinic Keratosis Drugs Revenue by Manufacturer (2017-2018)
Figure Global Actinic Keratosis Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Actinic Keratosis Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Actinic Keratosis Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Actinic Keratosis Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Global Actinic Keratosis Drugs Revenue and Growth Rate (2014-2019)
Table Global Actinic Keratosis Drugs Sales by Regions (2014-2019)
Table Global Actinic Keratosis Drugs Sales Market Share by Regions (2014-2019)
Table Global Actinic Keratosis Drugs Revenue by Regions (2014-2019)
Figure Global Actinic Keratosis Drugs Revenue Market Share by Regions in 2014
Figure Global Actinic Keratosis Drugs Revenue Market Share by Regions in 2018
Figure North America Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Europe Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure South America Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure North America Actinic Keratosis Drugs Revenue and Growth Rate (2014-2019)
Table North America Actinic Keratosis Drugs Sales by Countries (2014-2019)
Table North America Actinic Keratosis Drugs Sales Market Share by Countries (2014-2019)
Figure North America Actinic Keratosis Drugs Sales Market Share by Countries in 2014
Figure North America Actinic Keratosis Drugs Sales Market Share by Countries in 2018
Table North America Actinic Keratosis Drugs Revenue by Countries (2014-2019)
Table North America Actinic Keratosis Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Actinic Keratosis Drugs Revenue Market Share by Countries in 2014
Figure North America Actinic Keratosis Drugs Revenue Market Share by Countries in 2018
Figure United States Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Canada Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Europe Actinic Keratosis Drugs Revenue and Growth Rate (2014-2019)
Table Europe Actinic Keratosis Drugs Sales by Countries (2014-2019)
Table Europe Actinic Keratosis Drugs Sales Market Share by Countries (2014-2019)
Table Europe Actinic Keratosis Drugs Revenue by Countries (2014-2019)
Figure Europe Actinic Keratosis Drugs Revenue Market Share by Countries in 2017
Figure Europe Actinic Keratosis Drugs Revenue Market Share by Countries in 2018
Figure Germany Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure UK Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure France Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Russia Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Italy Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Actinic Keratosis Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Actinic Keratosis Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Actinic Keratosis Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Actinic Keratosis Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Actinic Keratosis Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Actinic Keratosis Drugs Revenue Market Share by Countries 2018
Figure China Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Japan Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Korea Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure India Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure South America Actinic Keratosis Drugs Revenue and Growth Rate (2014-2019)
Table South America Actinic Keratosis Drugs Sales by Countries (2014-2019)
Table South America Actinic Keratosis Drugs Sales Market Share by Countries (2014-2019)
Figure South America Actinic Keratosis Drugs Sales Market Share by Countries in 2018
Table South America Actinic Keratosis Drugs Revenue by Countries (2014-2019)
Table South America Actinic Keratosis Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Actinic Keratosis Drugs Revenue Market Share by Countries in 2018
Figure Brazil Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Actinic Keratosis Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Actinic Keratosis Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Actinic Keratosis Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Actinic Keratosis Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Actinic Keratosis Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Actinic Keratosis Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Actinic Keratosis Drugs Revenue Market Share by Countries in 2014
Figure Middle East and Africa Actinic Keratosis Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure UAE Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Actinic Keratosis Drugs Sales and Growth Rate (2014-2019)
Table Global Actinic Keratosis Drugs Sales by Type (2014-2019)
Table Global Actinic Keratosis Drugs Sales Share by Type (2014-2019)
Table Global Actinic Keratosis Drugs Revenue by Type (2014-2019)
Table Global Actinic Keratosis Drugs Revenue Share by Type (2014-2019)
Figure Global Nucleoside Metabolic Inhibitors Sales Growth (2014-2019)
Figure Global Nucleoside Metabolic Inhibitors Price (2014-2019)
Figure Global Immunomodulators Sales Growth (2014-2019)
Figure Global Immunomodulators Price (2014-2019)
Figure Global Photosensitizing Agents Sales Growth (2014-2019)
Figure Global Photosensitizing Agents Price (2014-2019)
Figure Global NSAIDs Sales Growth (2014-2019)
Figure Global NSAIDs Price (2014-2019)
Table Global Actinic Keratosis Drugs Sales by Application (2014-2019)
Table Global Actinic Keratosis Drugs Sales Share by Application (2014-2019)
Figure Global Pharmacies Sales Growth (2014-2019)
Figure Global Diagnostic Centers Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Actinic Keratosis Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Actinic Keratosis Drugs Sales Forecast by Regions (2019-2024)
Table Global Actinic Keratosis Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Actinic Keratosis Drugs Market Forecast (2019-2024)
Figure Europe Sales Actinic Keratosis Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Actinic Keratosis Drugs Market Forecast (2019-2024)
Figure South America Sales Actinic Keratosis Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Actinic Keratosis Drugs Market Forecast (2019-2024)
Table Global Actinic Keratosis Drugs Sales Forecast by Type (2019-2024)
Table Global Actinic Keratosis Drugs Market Share Forecast by Type (2019-2024)
Table Global Actinic Keratosis Drugs Sales Forecast by Application (2019-2024)
Table Global Actinic Keratosis Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
日光性角化症薬剤市場：世界及び中国市場分析・予測（～2024年） Actinic Keratosis Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Actinic Keratosis Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Actinic Keratosis Drug…- 日光（太陽）角化症治療市場：世界及び中国の市場分析・予測（～2024年） Actinic (Solar) Keratosis Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Actinic (Solar) Keratosis Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of th…
- 世界の非ステロイド系抗炎症薬（NSAID）市場：市場規模・現状・予測 Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 世界の脂漏性角化症の治療市場：市場規模・現状・予測 Seborrheic keratosis is one of the common noncancerous skin growths in older adults. The growths mostly appear on shoulders, back, abdomen, face, chest, and scalp. Cryosurgery is the most preferred method to remove the growth. The method uses liquid nitrogen to freeze off the growth.The Americas dom…
- 世界のペプチドベースの代謝障害治療薬市場：市場規模・現状・予測 A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive. Peptide therapeutics are used to treat metabolic disorders owing to their stability, effici…